Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Crizotinib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Crizotinib impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Crizotinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Our Crizotinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Crizotinib Related Compounds
Stable Isotopes
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| (R)-Crizotinib-d5 (piperidine-3,3,4,5,5-d5) | Stable Isotopes | CS-T-94563 | 1395950-84-1 | Enquire |
| Crizotinib D5 | Stable Isotopes | CS-T-51303 | 1395950-48-7 | Enquire |
| Crizotinib D8 | Stable Isotopes | CS-O-13177 | 1523579-82-9 | Enquire |
| Crizotinib metabolite hydrochloride 13C5, 15N | Stable Isotopes | CS-EK-01409 | 1415558-82-5 free base unlabeled | Enquire |
| Crizotinib-D9 | Stable Isotopes | CS-O-46494 | 1523580-59-7 | Enquire |
| Crizotinib-d9 Hydrochloride | Stable Isotopes | CS-O-54127 | 1523580-59-7 (Freebase) | In Stock |
API Standards
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Crizotinib | API Standards | CS-O-01256 | 877399-52-5 | Enquire |
Metabolites
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Crizotinib metabolite hydrochloride | Metabolites | CS-EK-02850 | 1415558-82-5 free base | Enquire |
Impurities
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| (R)-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-2-nitropyridin... | Impurities | CS-O-59985 | Not Available | Enquire |
| 1,2-bis(3-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin... | Impurities | CS-O-59986 | Not Available | Enquire |
| 2-Keto Crizotinib | Impurities | CS-T-30307 | 1415558-82-5 | In Stock |
| Crizotinib Amine Impurity | Impurities | CS-O-44017 | 877397-71-2 | In Stock |
| Crizotinib Dimer Impurity | Impurities | CS-O-59024 | Not Available | Enquire |
| Crizotinib Impurity 12 | Impurities | CS-O-59767 | 704-09-6 | Enquire |
| Crizotinib Impurity 14 | Impurities | CS-O-59018 | Not Available | Enquire |
| Crizotinib Impurity 16 | Impurities | CS-O-59019 | 2509276-77-9 | Enquire |
| Crizotinib Impurity 17 | Impurities | CS-O-59020 | 2509276-79-1 | Enquire |
| Crizotinib Impurity 19 | Impurities | CS-O-59021 | Not Available | Enquire |
| Crizotinib Impurity 23 | Impurities | CS-O-59022 | Not Available | Enquire |
| Crizotinib Impurity 24 | Impurities | CS-O-59023 | Not Available | Enquire |
| Crizotinib piperidin-1-Hydroxy Impurity | Impurities | CS-O-50144 | Not Available | In Stock |
| N-Boc Crizotinib | Impurities | CS-O-46681 | 877399-51-4 | In Stock |
| Rac Crizotinib | Impurities | CS-M-42685 | 877400-66-3 | Enquire |
Intermediates
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| (S)-Crizotinib | Intermediates | CS-T-90635 | 1374356-45-2 | In Stock |